- Home
- REPL vs FSBC Comparison
REPL vs FSBC Comparison
Compare REPL & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- FSBC
- Stock Information
- Founded
- REPL 2015
- FSBC 2002
- Country
- REPL United States
- FSBC United States
- Employees
- REPL N/A
- FSBC N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- FSBC Banks
- Sector
- REPL Health Care
- FSBC Finance
- Exchange
- REPL Nasdaq
- FSBC Nasdaq
- Market Cap
- REPL 578.4M
- FSBC 581.0M
- IPO Year
- REPL 2018
- FSBC 2021
- Fundamental
- Price
- REPL $7.71
- FSBC $28.32
- Analyst Decision
- REPL Strong Buy
- FSBC Buy
- Analyst Count
- REPL 6
- FSBC 4
- Target Price
- REPL $20.00
- FSBC $34.75
- AVG Volume (30 Days)
- REPL 1.1M
- FSBC 51.2K
- Earning Date
- REPL 05-19-2025
- FSBC 04-28-2025
- Dividend Yield
- REPL N/A
- FSBC 2.82%
- EPS Growth
- REPL N/A
- FSBC N/A
- EPS
- REPL N/A
- FSBC 2.27
- Revenue
- REPL N/A
- FSBC $124,973,000.00
- Revenue This Year
- REPL $31.16
- FSBC $24.73
- Revenue Next Year
- REPL N/A
- FSBC $13.73
- P/E Ratio
- REPL N/A
- FSBC $12.47
- Revenue Growth
- REPL N/A
- FSBC 11.14
- 52 Week Low
- REPL $4.92
- FSBC $21.72
- 52 Week High
- REPL $17.00
- FSBC $35.13
- Technical
- Relative Strength Index (RSI)
- REPL 39.21
- FSBC 59.31
- Support Level
- REPL $6.93
- FSBC $27.53
- Resistance Level
- REPL $10.30
- FSBC $29.84
- Average True Range (ATR)
- REPL 0.73
- FSBC 1.15
- MACD
- REPL -0.07
- FSBC 0.22
- Stochastic Oscillator
- REPL 23.15
- FSBC 63.36
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.